Sources | Names Used |
---|---|
CTRPv2 | selumetinib:BRD-A02303741 (4:1 mol/mol) |
PharmacoGx | selumetinib:BRD-A02303741 (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PPP3CC | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-05 |
mRNA | EID2 | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-05 |
mRNA | H1FX | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-05 |
mRNA | MYEF2 | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-05 |
mRNA | SERAC1 | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-05 |
mRNA | CLGN | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-05 |
mRNA | C18orf54 | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-05 |
mRNA | GRK3 | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-05 |
mRNA | CHST11 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
mRNA | LYZ | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |